Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Statin treatment prevents increased cardiovascular and all-cause mortality associated with clarithromycin in patients with stable coronary heart disease.

Jensen GB, Hilden J, Als-Nielsen B, Damgaard M, Hansen JF, Hansen S, Helø OH, Hildebrandt P, Kastrup J, Kolmos HJ, Kjøller E, Lind I, Nielsen H, Petersen L, Jespersen CM, Gluud C; CLARICOR Trial Group.

J Cardiovasc Pharmacol. 2010 Feb;55(2):123-8. doi: 10.1097/FJC.0b013e3181c87e37.

PMID:
19920766
2.

Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease.

Gluud C, Als-Nielsen B, Damgaard M, Fischer Hansen J, Hansen S, Helø OH, Hildebrandt P, Hilden J, Jensen GB, Kastrup J, Kolmos HJ, Kjøller E, Lind I, Nielsen H, Petersen L, Jespersen CM; CLARICOR Trial Group.

Cardiology. 2008;111(4):280-7. doi: 10.1159/000128994. Epub 2008 May 2.

3.

Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.

Winkel P, Hilden J, Hansen JF, Kastrup J, Kolmos HJ, Kjøller E, Jensen GB, Skoog M, Lindschou J, Gluud C; CLARICOR trial group.

Int J Cardiol. 2015 Mar 1;182:459-65. doi: 10.1016/j.ijcard.2015.01.020. Epub 2015 Jan 6.

PMID:
25602299
4.

Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease.

Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, Anderson JL; Intermountain Heart Collaborative (IHC) Study Group.

Circulation. 2003 Jan 21;107(2):258-63.

5.

Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

Collard CD, Body SC, Shernan SK, Wang S, Mangano DT; Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2006 Aug;132(2):392-400.

PMID:
16872968
6.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
7.

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients.

Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL; Intermountain Heart Collaborative Study.

J Am Coll Cardiol. 2002 Nov 20;40(10):1777-85.

8.

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, Bittner V, Schrott HG, Blumenthal RS, Levy R; HERS Study Group.

Circulation. 2002 Jun 25;105(25):2962-7.

9.
10.

Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery.

Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, van Urk H, Poldermans D.

Am J Med. 2004 Jan 15;116(2):96-103.

PMID:
14715323
11.

Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.

Jespersen CM, Kolmos HJ, Frydendall N, Hilden J, Gluud C, Hansen JF; CLARICOR Trial Group.

J Antimicrob Chemother. 2009 Aug;64(2):411-5. doi: 10.1093/jac/dkp190. Epub 2009 May 28.

12.

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.

Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.

Clin Ther. 2007 Feb;29(2):253-60.

PMID:
17472818
13.

Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.

Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD.

Circulation. 2004 Sep 14;110(11 Suppl 1):II45-9.

14.

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Athyros VG, Elisaf M, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Milionis HJ, Mikhailidis DP; GREACE Study Collaborative Group.

Am J Kidney Dis. 2004 Apr;43(4):589-99.

PMID:
15042535
15.

Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention.

Kubota N, Kasai T, Miyauchi K, Njaman W, Kajimoto K, Akimoto Y, Kojima T, Ken Y, Takeshi K, Hiroyuki D.

Heart Vessels. 2008 Jan;23(1):35-9. doi: 10.1007/s00380-007-1007-8. Epub 2008 Feb 14.

PMID:
18273544
16.

Long-term (11-year) statin therapy following percutaneous coronary intervention improves clinical outcome and is not associated with increased malignancy.

Kasai T, Miyauchi K, Kurata T, Satoh H, Ohta H, Tanimoto K, Kawamura M, Okazaki S, Yokoyama K, Kojima T, Akimoto Y, Daida H.

Int J Cardiol. 2007 Jan 8;114(2):210-7. Epub 2006 Jun 23.

PMID:
16797744
17.

Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.

Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators.

Circ J. 2008 Dec;72(12):1937-45. Epub 2008 Oct 24.

18.
19.

Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.

Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, Kamler M, Massoudy P, Erbel R, Jakob H.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1143-9.

PMID:
17976441
20.

The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.

Ward RP, Leeper NJ, Kirkpatrick JN, Lang RM, Sorrentino MJ, Williams KA.

Int J Cardiol. 2005 Oct 10;104(3):264-8.

PMID:
16186054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk